共有 50 笔近期内部人交易记录记录，涉及 Alpine Immune Sciences, Inc. (ALPN), 包括 13 笔买入 和 37 笔卖出. 内部人买入总额为 $2.7M 内部人卖出总额为 $559.86M.
近期活跃的重要内部人包括 Conway Robert E, Gold Mitchell, Topper James N. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — ALPN
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-05-20 |
Conway Robert E |
Director |
股份退回 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Gold Mitchell |
Executive Chairman and CEO |
股份退回 |
240,000 |
$18.33 |
$4.4M |
- |
| 2024-05-20 |
Topper James N |
Director |
股份退回 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Thompson Peter A. |
Director |
股份退回 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Cui Xiangmin |
10 Percent Owner |
股份退回 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Rickey James Paul |
See Remarks |
股份退回 |
78,000 |
$18.33 |
$1.43M |
- |
| 2024-05-20 |
Peetz Christopher |
Director |
股份退回 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Peng Stanford L |
See Remarks |
股份退回 |
120,000 |
$18.33 |
$2.2M |
- |
| 2024-05-20 |
Hernday Natasha |
Director |
股份退回 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Drappa Jorn |
Director |
股份退回 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Durand Remy |
Chief Business Officer |
股份退回 |
78,000 |
$18.33 |
$1.43M |
- |
| 2024-05-20 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
股份退回 |
14,600 |
$35.89 |
$523.99K |
- |
| 2024-05-18 |
Orbimed Advisors Llc |
Director |
要约收购（卖出） |
264,315 |
$65.00 |
$17.18M |
- |
| 2024-05-18 |
Gold Mitchell |
Executive Chairman and CEO |
要约收购（卖出） |
2,627,157 |
$65.00 |
$170.77M |
- |
| 2024-05-18 |
Topper James N |
Director |
要约收购（卖出） |
2,829,347 |
$65.00 |
$183.91M |
- |
| 2024-05-18 |
Thompson Peter A. |
Director |
要约收购（卖出） |
264,315 |
$65.00 |
$17.18M |
- |
| 2024-05-18 |
Cui Xiangmin |
10 Percent Owner |
要约收购（卖出） |
1,735,544 |
$65.00 |
$112.81M |
- |
| 2024-05-08 |
Gold Mitchell |
Executive Chairman and CEO |
期权行权 |
13,245 |
$7.55 |
$100K |
109,245 |
| 2024-05-08 |
Peng Stanford L |
See Remarks |
期权行权（卖出） |
161,492 |
$0.65 |
$104.97K |
- |
| 2024-05-08 |
Durand Remy |
Chief Business Officer |
期权行权（卖出） |
10,000 |
$4.76 |
$47.6K |
- |
| 2024-05-08 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
期权行权 |
22,820 |
$12.07 |
$275.44K |
30,120 |
| 2024-05-07 |
Rickey James Paul |
See Remarks |
期权行权（卖出） |
398 |
$5.02 |
$2K |
137 |
| 2024-04-25 |
Topper James N |
Director |
实值期权行权 |
1,200,000 |
$0.00 |
$1.2K |
- |
| 2024-04-03 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
处置 |
14,600 |
$35.89 |
$523.99K |
- |
| 2024-01-26 |
Rickey James Paul |
See Remarks |
知情卖出 |
73,764 |
$22.31 |
$1.65M |
- |
| 2024-01-25 |
Rickey James Paul |
See Remarks |
知情卖出 |
236 |
$22.00 |
$5.19K |
- |
| 2024-01-18 |
Cui Xiangmin |
10 Percent Owner |
实值期权行权 |
1,234,636 |
$12.74 |
$15.73M |
- |
| 2024-01-18 |
Decheng Capital China Life Sciences Usd Fund Iii, L.p. |
10 Percent Owner |
实值期权行权 |
1,234,636 |
$12.74 |
$15.73M |
- |
| 2024-01-11 |
Orbimed Advisors Llc |
Director |
实值期权行权 |
145,251 |
$12.74 |
$1.85M |
- |
| 2024-01-11 |
Thompson Peter A. |
Director |
实值期权行权 |
145,251 |
$12.74 |
$1.85M |
- |
| 2024-01-04 |
Gold Mitchell |
Executive Chairman and CEO |
限制性股票授予 (RSU) |
96,000 |
- |
- |
96,000 |
| 2024-01-04 |
Rickey James Paul |
See Remarks |
限制性股票授予 (RSU) |
31,200 |
- |
- |
31,200 |
| 2024-01-04 |
Peng Stanford L |
See Remarks |
限制性股票授予 (RSU) |
48,000 |
- |
- |
72,371 |
| 2024-01-04 |
Durand Remy |
Chief Business Officer |
限制性股票授予 (RSU) |
31,200 |
- |
- |
38,104 |
| 2024-01-02 |
Conway Robert E |
Director |
限制性股票授予 (RSU) |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Topper James N |
Director |
限制性股票授予 (RSU) |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Thompson Peter A. |
Director |
限制性股票授予 (RSU) |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Cui Xiangmin |
10 Percent Owner |
限制性股票授予 (RSU) |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Peetz Christopher |
Director |
限制性股票授予 (RSU) |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Hernday Natasha |
Director |
限制性股票授予 (RSU) |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Drappa Jorn |
Director |
限制性股票授予 (RSU) |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2023-12-28 |
Orbimed Advisors Llc |
Director |
知情卖出 |
139,166 |
$18.32 |
$2.55M |
264,315 |
| 2023-12-28 |
Gold Mitchell |
Executive Chairman and CEO |
期权行权（卖出） |
74,441 |
$12.74 |
$948.38K |
- |
| 2023-12-28 |
Thompson Peter A. |
Director |
知情卖出 |
139,166 |
$18.32 |
$2.55M |
264,315 |
| 2023-12-27 |
Gold Mitchell |
Executive Chairman and CEO |
知情卖出 |
29,573 |
$20.04 |
$592.72K |
- |
| 2023-12-27 |
Orbimed Advisors Llc |
Director |
知情卖出 |
18,922 |
$19.96 |
$377.68K |
406,609 |
| 2023-12-27 |
Thompson Peter A. |
Director |
知情卖出 |
18,922 |
$19.96 |
$377.68K |
406,609 |
| 2023-12-26 |
Gold Mitchell |
Executive Chairman and CEO |
期权行权（卖出） |
2,402 |
$0.45 |
$1.08K |
- |
| 2023-12-22 |
Gold Mitchell |
Executive Chairman and CEO |
知情卖出 |
37,825 |
$20.43 |
$772.59K |
- |
| 2023-12-19 |
Gold Mitchell |
Executive Chairman and CEO |
知情卖出 |
2,402 |
$20.01 |
$48.06K |
- |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
